• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemolysis (1886); Stenosis (2263); Hemorrhagic Stroke (4417); Ischemia Stroke (4418); Lactate Dehydrogenase Increased (4567)
Event Date 06/24/2022
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient suffered an ischemic stroke with hemorrhagic conversion that was diagnosed on (b)(6) 2022.The patient had an altered mental status post-stroke with stable serial head computed tomography (ct) scans.It was noted that the patient had worsening neurological status.The patient's anticoagulation was held.They were closely monitored in the intensive care unit (icu).They had an overnight increase in aspartate aminotransferase (ast), alanine aminotransferase (alt), and lactate dehydrogenase (ldh).There were no changes to pump parameters.There was evidence of hemolysis but pump thrombus was ruled out.Once the ct scans were stable, the patient was restarted on heparin drip and then coumadin (warfarin) per neurology's recommendation.It was noted that the patient had 70% stenosis of their left internal carotid artery that would be addressed in the future.The patient remained hospitalized in the intermediate care unit (imc).The patient was non-verbal.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct correlation between heartmate 3 left ventricular assist system (lvas), serial number (b)(6), and the reported event could not conclusively be established through this evaluation.The submitted system controller event log file contained data from (b)(6) 2022 through (b)(6) 2022.The file was unremarkable and the pump appeared to operate as intended at the set speed.The patient remains ongoing on heartmate 3 lvas, serial number (b)(6).No further related events have been reported at this time.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 01jun2022.The heartmate 3 lvas instruction for use (ifu), rev.C, is currently available.Section 1 of this document lists stroke, bleeding, hemolysis, and other neurological events as adverse events that may be associated with the use of the heartmate 3 left ventricular assist system.Section 1 provides an explanation of all pump parameters.Section 6 entitled ¿patient care and management¿ also lists neurological dysfunction as a potential late postimplant complication.Section 6 ¿patient care and management¿ (under "anticoagulation") also outlines the recommended anticoagulation regimen (including international normalized ratio (inr) range) for patients using the heartmate 3 lvas as well as the suggested anticoagulation modifications.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key15114835
MDR Text Key296714814
Report Number2916596-2022-12165
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/18/2024
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number8485092
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/06/2022
Initial Date FDA Received07/27/2022
Supplement Dates Manufacturer Received10/25/2022
Supplement Dates FDA Received10/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age74 YR
Patient SexMale
Patient Weight94 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-